Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS<sup>G12C</sup> mutation: a randomised, open-label, phase 3 trial
Amgen
Adrianus Johannes de Langen; Melissa L Johnson; Julien Mazieres; Anne-Marie C Dingemans; Giannis Mountzios; Miklos Pless; Jürgen Wolf; Martin Schuler; Hervé Lena; Ferdinandos Skoulidis; Yasuto Yoneshima; Sang-We Kim; Helena Linardou; Silvia Novello; Anthonie J van der Wekken; Yuanbin Chen; Solange Peters; Enriqueta Felip; Benjamin J Solomon; Suresh S Ramalingam; Christophe Dooms; Colin R Lindsay; Carlos Gil Ferreira; Normand Blais; Cynthia C Obiozor; Yang Wang; Bhakti Mehta; Tracy Varrieur; Gataree Ngarmchamnanrith; Björn Stollenwerk; David Waterhouse; Luis Paz-Ares; CodeBreaK 200 Investigators